Arun Swaminath (A Swaminath)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Venous Thromboembolism

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Crohn's & colitis 360

Journal of clinical medicine research

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey A Lowell, Garvita Sharma, Arun Swaminath, Keith Sultan
Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis. Inflammatory bowel diseases (2024)
Alexandra Feathers, Gina S Lovasi, Zoya Grigoryan, Kade Beem, Samit K Datta, David M Faleck, Thomas Socci, Rachel Maggi, Arun Swaminath
Crohn's Disease Mortality and Ambient Air Pollution in New York City. Inflammatory bowel diseases (2023)
Yonatan Ziv, Arun Swaminath, Keith Sultan
Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical. Inflammatory bowel diseases 28 (10) (2022)
Jonathan M Schachne, Laura L Durbin, Corey R Lacher, Maheep Sangha, Anjali Mone, Arun Swaminath
Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions. Crohn's & colitis 360 3 (4) (2021)
Ceena Chandrabos, Kana Chin, Yan Liu, Nina Kohn, Arun Swaminath, Keith Sultan
Clostridiodes difficile Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease. Journal of clinical medicine research 13 (12) (2021)
Jonathan M Schachne, Laura L Durbin, Corey R Lacher, Maheep Sangha, Anjali Mone, Arun Swaminath
Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions. Crohn's & colitis 360 3 (4) (2021)
Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer, Gursimran Kochhar, Brigid Boland, Siddharth Singh, Robert P Hirten, Ryan C Ungaro, Eugenia Shmidt, Karen Lasch, Vipul Jairaith, David Hudesman, Shannon Chang, Dana Lukin, Arun Swaminath, Bruce E Sands, Jean Frederic Colombel, Sunanda Kane, Edward V Loftus, Bo Shen, Corey A Siegel, William J Sandborn, Parambir S Dulai, null null
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Alimentary pharmacology & therapeutics 52 (4) (2020)
A Feathers, Arun Swaminath, A N Ananthakrishnan, L Falzon, S Li Ferry
Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics 46 (11-12) (2017)
A Feathers, Arun Swaminath, A N Ananthakrishnan, L Falzon, S Li Ferry
Letter: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics 46 (10) (2017)
Arun Swaminath, A Feathers, A N Ananthakrishnan, L Falzon, S Li Ferry
Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Alimentary pharmacology & therapeutics 46 (7) (2017)